During the past decade, Stockholm CF Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stockholm CF Center" #1 collaborator was "Hadassah Medical Organization" with 1 trials as a collaborator and "Vertex Pharmaceuticals Incorporated" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Stockholm CF Center" are "Cystic Fibrosis" (2 trials) and "Healthy Volunteer" (1 trials). Many other conditions were trialed in "Stockholm CF Center" in a lesser frequency.

Most popular intervention types in "Stockholm CF Center" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "PTI-801" (1 trials), "PTI-808" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Stockholm CF Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Stockholm CF Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Stockholm CF Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Stockholm CF Center, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".